CannabisNewsWire
Editorial Coverage: Dating back thousands of years, people have
found ways to treat pain and other ailments with cannabidiol (CBD)
oil which is harvested from the hemp plant. However, the natural
healing properties of CBD are being jeopardized by the advent of
man-made synthetic CBDs. These chemical analogs are dangerous
imitations of plant-derived product, binding to human
endocannabinoid receptors at astronomically larger quantities than
natural cannabinoids. These designer drugs prompted the U.S.
Centers for Disease Control and Prevention to issue a national health
alert warning about synthetic cannabinoids. Shunning
synthetics, Marijuana Company of America, Inc. (OTC: MCOA)
(MCOA
Profile) provides consumers complete transparency and
delivering only pure, plant-based 100% hemp-derived products
through its hempSMART™ brand. While Medical Marijuana, Inc.
(OTC: MJNA) and PotNetwork Holding, Inc. (OTC:
POTN) market hemp-derived CBD products, some companies
such as Isodiol International, Inc. (CSE: ISOL) (OTC:
ISOLF) (FSE: LB6A.F) and CV Sciences, Inc. (OTC:
CVSI) utilize extraction techniques to produce isolated
cannabinoid compounds for both commercial and/or research uses.
Surging Demand Creates Copy Cats
Hemp-derived CBD grew from a market category that didn’t exist
five years ago to generating $190 million in sales in 2017. The
U.S. industry is poised to reach $1 billion dollars in 2018, led by
hemp-derived CBD, food, personal care and industrial products.
Hemp Business Journal estimates the
U.S. hemp industry will grow to a $2.6 billion market by 2022 with
an estimated five-year CAGR of 25%.
In a recent
article, “Fighting fakes: Hemp leaders on the dangers of
synthetic CBD,” public health investigators issued warnings when 50
people were sickened after consuming synthetic CBD. What the
epidemiologists found was that the products, while labeled CBD, did
not contain CBD compounds. Instead, the products contained a
synthetically produced cannabinoid.
CBD products are often mislabeled, both in how much CBD the
products contain and where the CBD comes from. A study published in JAMA revealed that nearly 70% of
online CBD marijuana extracts are mislabeled, some had extra CBD,
some less, and some contained hidden CBDs. Blind testing found that
only about 31% of the extracts tested contained the amount of CBD
listed on the label.
Differentiated from Others
The company’s commitment to quality may differentiate Marijuana
Company of America, Inc. (OTC:MCOA) from all others in the
sector. MCOA uses the highest-quality sourced raw materials to
produce the finest quality botanical supplements and topicals on
the market. To ensure quality and transparency, the company’s
hempSMART™ product line has been rigorously tested to validate its
purity. Products developed by hempSMART are derived and formulated
from industrial hemp containing naturally occurring CBD compounds
that help support the body’s natural endocannabinoid system. All
hempSMART™ products contain tested levels and clinically researched
ingredients designed to meet and exceed consumers expectations.
The company is led by cannabis industry pioneer Donald
Steinberg, MCOA’s CEO and an experienced veteran of the cannabis
and industrial hemp industries. Steinberg founded the first
marijuana company ever to trade on a U.S. stock market, and his
extensive background and knowledge of the industry may give the
company unparalleled insights into the global industrial hemp and
cannabis markets.
Celebrated Family of Products
Derived from industrial hemp containing CBD compounds, MCOA’s
hempSMART™ product line is among the finest quality of botanical
supplements on the market. Scientifically driven, each of MCOA’s
hempSMART™ products are created to ensure only the highest quality
products reach discerning consumers. MCOA’s hempSMART™ CBD consumer
products are researched, developed and sold at www.hempsmart.com.
The company recently re-launched its patent-pending wellness
nootropic product hempSMART™ Brain, a “first of its kind”
researched formulation for optimal brain function support, with
300mg of full spectrum CBD per bottle. HempSMART products also
include full spectrum bioavailable CBD drops in form of a tincture
containing a high concentration and potency of CBD, hempSMART ™
Pain capsules with a blend of premium CBD and botanical
supplements, and hempSMART ™ Pain Cream with a synergistic
combination of natural botanicals and full spectrum hemp extract to
treat aching muscles and joints. In addition, the company now
provides hempSMART™ Full Spectrum Pet Drops, exclusively designed
for fur-bearing family members.
To virally expand sales, MCOA created its own unique hempSMART
affiliate network marketing program. The affiliate marketing
program provides a generous compensation plan to promote and sell
hempSMART’s CBD consumer products in the United States. Advocates
of hempSMART’s CBD products make the best ambassadors and the sales
model lends itself to rapid global expansion.
Diversified Opportunity
In addition to the research and development of hemp-based
consumer products, MCOA is strategically expanding its footprint
across multiple facets of the hemp industry, building a portfolio
of diversified investments and joint ventures to grow the company
and potentially drive shareholder value.
The company recently provided
updates on its 125-acre industrial hemp cultivation project in
northeast New Brunswick with joint-venture partner Global Hemp
Group Inc. (OTC: GBHPF). Planting on the first 77 acres is complete
and the remaining 48 acres will be seeded soon. Drying equipment is
being evaluated to process the biomass after harvest and management
is in discussions with several potential processing partners for
the material.
To target impulse buys in high traffic convenience stores, MCOA
secured a 25% equity stake in Convenient Hemp Mart, LLC’s BeniHemp
branded products. BeniHemp products will include topicals,
tinctures, and edibles packaged in one-day, two-day, and 30-day
supplies distributed to convenience stores, smoke shops, gas
stations and similar small retail businesses.
Each owning 42.5%, MCOA and Global Hemp Group formed a joint
venture, Covered Bridge Acres LTD., to develop a high yielding CBD
hemp cultivation project in Oregon and committed to jointly invest
a total of US$1.2 million into the project. A cornerstone of the
project is the acquisition of a 109-acre agricultural property in
Scio, Oregon. The property, located 70 miles south of Portland, is
situated in the fertile Willamette Valley and has a history of hemp
cultivation over the past two years. The farm is ideal for
cultivating hemp as it contains a high level of organic matter in
the soil and has an established irrigation infrastructure with
sufficient water rights.
MCOA successfully raised $1 million in funding for Bougainville
Ventures to construct and manage a turnkey state of the art
cannabis cultivation and processing facility. The joint venture has
completed the setup of 10,000 sq. ft. of greenhouse space and
waiting for completion of inspection, the final step before
commencing cultivation.
Active Companies Vying for Market Position
CV Sciences (OTCQB: CVSI) operates two business
segments: a drug development division focused on developing and
commercializing novel therapeutics utilizing naturally occurring
CBD; and, a consumer product division focused on manufacturing,
marketing and selling plant-based CBD products to a range of market
sectors. The company recently announced the June 7, 2018,
publication of the toxicology and safety results of an extract from
the base raw materials used in its PlusCBD Oil™ consumer products.
The study, designed
to investigate the safety of oral consumption of the company’s hemp
CBD oil and to support a Generally Recognized as Safe (GRAS)
Independent Conclusion, concluded that the test article was
non-mutagenic, non-clastogenic and non-genotoxic.
Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE:
LB6A.F) is focused on pharmaceutical grade phytochemical
compounds and is among industry leaders in the manufacture and
development of consumer products. The company pioneered the
commercialization of 99%+ pure, pharmaceutical grade cannabinoids,
micro-encapsulations, and nanotechnology for consumable and topical
skin care products. Isodiol earlier this month
entered into a binding agreement to acquire 51% of Round Mountain
Technologies, LLC (“RMT”), a cultivator of organic hemp with
operations in Nevada.
Medical Marijuana (OTC: MJNA), the first
publicly traded cannabis company in the United States (founded by
current CEO of Marijuana Company of America Don Steinberg),
develops, distribute and sells hemp oil that contains naturally
occurring cannabinoids, including CBD and other products containing
CBD oil. In recent news, MJNA announced its favor on the Drug
Enforcement Administration’s (DEA) recent statement on the legality
of CBD -- which further clarifies that some CBD products, such as
hemp-derived CBD products, are legal to distribute throughout the
United States and do not fall under the regulations of the
Controlled Substances Act (CSA). Additionally, the company’s
HempMeds® subsidiary reported the historic
authorization of its Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp
oil product for import into Argentina.
PotNetwork Holding (OTC: POTN) is a holding
company for its subsidiaries, First Capital Venture Co. that owns
Diamond CBD, Inc., the maker of Diamond CBD oils. Diamond CBD
researches, develops and markets hemp extracts that contain a broad
range of cannabinoids and hemp derivatives. The company recently announced that Diamond CBD’s online sales
increased 639% higher than the year prior. PotNetwork is in
currently preparing to file with the SEC to
become a fully reporting company.
With an estimated 25% compound annual growth rate, there’s
little doubt the about the trajectory of the CBD market. As the
market continues its rapid expansion and more people become aware
of the dangers lurking in synthetic CBD, it seems reasonable that
evermore consumers will gravitate toward high-quality natural CBD
product. Companies like MCOA aim to answer that call.
For more information on Marijuana Company of America, visit
Marijuana
Company of America, Inc. (OTC: MCOA)
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides
(1) access to our news aggregation and syndication servers, (2)
CannabisNewsBreaks that summarize
corporate news and information, (3) enhanced press release
services, (4) social media distribution and optimization services,
and (5) a full array of corporate communication solutions. As a
multifaceted financial news and content distribution company with
an extensive team of contributing journalists and writers, CNW is
uniquely positioned to best serve private and public companies that
desire to reach a wide audience of investors, consumers,
journalists and the general public. CNW has an ever-growing
distribution network of more than 5,000 key syndication outlets
across the country. By cutting through the overload of information
in today’s market, CNW brings its clients unparalleled visibility,
recognition and brand awareness. CNW is where news, content and
information converge.
Receive Text Alerts
from CannabisNewsWire: Text "Cannabis" to
21000
For more information please visit https://www.CannabisNewsWire.com and
or https://CannabisNewsWire.News
Please see full terms of use and disclaimers on the
CannabisNewsWire website applicable to all content provided by CNW,
wherever published or re-published: http://CNW.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article
and content set forth above. References to any issuer other than
the profiled issuer are intended solely to identify industry
participants and do not constitute an endorsement of any issuer and
do not constitute a comparison to the profiled issuer. The
commentary, views and opinions expressed in this release by CNW are
solely those of CNW. Readers of this Article and content agree that
they cannot and will not seek to hold liable CNW for any investment
decisions by their readers or subscribers. CNW is a news
dissemination and financial marketing solutions provider and is NOT
registered broker-dealers/analysts/investment advisers, hold no
investment licenses and may NOT sell, offer to sell or offer to buy
any security.
The Article and content related to the profiled company
represent the personal and subjective views of the Author, and are
subject to change at any time without notice. The information
provided in the Article and the content has been obtained from
sources which the Author believes to be reliable. However, the
Author has not independently verified or otherwise investigated all
such information. None of the Author, CNW, or any of their
respective affiliates, guarantee the accuracy or completeness of
any such information. This Article and content are not, and should
not be regarded as investment advice or as a recommendation
regarding any particular security or course of action; readers are
strongly urged to speak with their own investment advisor and
review all of the profiled issuer’s filings made with the
Securities and Exchange Commission before making any investment
decisions and should understand the risks associated with an
investment in the profiled issuer’s securities, including, but not
limited to, the complete loss of your investment.
CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E the Securities Exchange Act of 1934, as amended and
such forward-looking statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. “Forward-looking statements” describe future expectations,
plans, results, or strategies and are generally preceded by words
such as “may”, “future”, “plan” or “planned”, “will” or “should”,
“expected,” “anticipates”, “draft”, “eventually” or “projected”.
You are cautioned that such statements are subject to a multitude
of risks and uncertainties that could cause future circumstances,
events, or results to differ materially from those projected in the
forward-looking statements, including the risks that actual results
may differ materially from those projected in the forward-looking
statements as a result of various factors, and other risks
identified in a company’s annual report on Form 10-K or 10-KSB and
other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this
release are made as of the date hereof and CNW undertakes no
obligation to update such statements.
Source:
CannabisNewsWire
Contact:
CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.net
Isodiol (CE) (USOTC:ISOLF)
Historical Stock Chart
From Nov 2024 to Dec 2024
Isodiol (CE) (USOTC:ISOLF)
Historical Stock Chart
From Dec 2023 to Dec 2024
